Inpharma Weekly

, Volume 1385, Issue 1, pp 30–30 | Cite as

US market news

News item


Oxybutynin Belimumab Agalsidase Beta Orphan Drug Designation Premarin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2003

Personalised recommendations